Miist Therapeutics is setting a new standard in acute care with inhaled therapies that work in seconds, not hours.
Investors 1
Funding Rounds 1
| Date | Series | Amount | Investors |
| 13.02.2025 | Seed | $7M | - |
Mentions in press and media 4
| Date | Title | Description |
| 13.02.2025 | Miist Therapeutics: $7 Million (Seed) Raised For Creating Instant-Acting Medicine | Miist Therapeutics, a physics-based developer of inhaled medicines, announced $7 million in seed funding from investors including Refactor Capital, 1517 Fund, Freeflow Ventures, Entrepreneur First, and California Innovation Fund. And Miist ... |
| 06.02.2025 | Miist Therapeutics: Breathing New Life into Medicine with $7M Funding | In the bustling world of healthcare innovation, Miist Therapeutics stands out like a lighthouse in a storm. The Alameda, California-based company has just secured $7 million in seed funding, a financial boost that promises to propel its gro... |
| 05.02.2025 | Miist Therapeutics Raises $7M in Funding | Miist Therapeutics, an Alameda CA-based physics-based developer of inhaled medicines, raised $7M in funding.
Backers included Refactor Capital, 1517 Fund, Freeflow Ventures, Entrepreneur First, and California Innovation Fund, among others.
... |
| 05.02.2025 | Miist Therapeutics Raises $7M to Develop Inhaled Medicines with Physics-Based Approach | What You Should Know:
– Miist Therapeutics, a pioneering company developing inhaled medicines with a focus on rapid drug delivery raises $7M ina seed funding round led by Refactor Capital with participation from 1517 Fund, Freeflow Ventures... |
Reviews 0
